中华临床医师杂志(电子版)
中華臨床醫師雜誌(電子版)
중화림상의사잡지(전자판)
CHINESE JOURNAL OF CLINICIANS(ELECTRONIC VERSION)
2014年
21期
3778-3780
,共3页
张建梅%于子燕%王大勇%刘晓丹%杨净%于荣波
張建梅%于子燕%王大勇%劉曉丹%楊淨%于榮波
장건매%우자연%왕대용%류효단%양정%우영파
烟酰胺磷酸核糖基转移酶%糖尿病,2型%网膜素%代谢综合征
煙酰胺燐痠覈糖基轉移酶%糖尿病,2型%網膜素%代謝綜閤徵
연선알린산핵당기전이매%당뇨병,2형%망막소%대사종합정
Nicotinamide phosphoribosyltransferase%Diabetes mellitus,type 2%Omentin%Metabolic syndrome
目的:观察合并代谢综合征的老年2型糖尿病患者血清内脂素(Visfatin)、网膜素(Omentin)水平变化及其影响因素。方法选用病例-对照研究,共入选120例,病例组根据代谢综合征及2型糖尿病诊断标准入选合并代谢综合征的老年2型糖尿病患者60例,同期入选年龄、性别匹配的60例健康体检者为对照组,酶联免疫吸附法检测内脂素、网膜素,常规测量身高、体重、血压,计算BMI、HOMR-IR,检测空腹血糖、空腹胰岛素、总胆固醇、甘油三酯等指标,比较两组内脂素、网膜素水平,并将内脂素、网膜素与其他指标进行相关分析。结果合并代谢综合征的老年2型糖尿病患者血清内脂素、网膜素水平降低[内脂素:(1.08±0.69)μg/L vs.(4.06±1.04)μg/L,网膜素(9.29±6.53)μg/L vs.(14.87±7.57)μg/L,P均<0.01],血清内脂素与BMI(r=-0.331)、HOMA-IR (r=-0.634)、WHR(r=-0.118)、FPG(r=-0.59)呈负相关,血清网膜素与BMI(r=-0.323)、HOMA-IR(r=-0.338)、WHR(r=-0.149)、FPG(r=-0.346)均呈负相关。结论合并代谢综合征的老年2型糖尿病患者血清内脂素、网膜素水平降低,并与BMI、HOMR-IR、腰臀比、空腹血糖呈负相关。
目的:觀察閤併代謝綜閤徵的老年2型糖尿病患者血清內脂素(Visfatin)、網膜素(Omentin)水平變化及其影響因素。方法選用病例-對照研究,共入選120例,病例組根據代謝綜閤徵及2型糖尿病診斷標準入選閤併代謝綜閤徵的老年2型糖尿病患者60例,同期入選年齡、性彆匹配的60例健康體檢者為對照組,酶聯免疫吸附法檢測內脂素、網膜素,常規測量身高、體重、血壓,計算BMI、HOMR-IR,檢測空腹血糖、空腹胰島素、總膽固醇、甘油三酯等指標,比較兩組內脂素、網膜素水平,併將內脂素、網膜素與其他指標進行相關分析。結果閤併代謝綜閤徵的老年2型糖尿病患者血清內脂素、網膜素水平降低[內脂素:(1.08±0.69)μg/L vs.(4.06±1.04)μg/L,網膜素(9.29±6.53)μg/L vs.(14.87±7.57)μg/L,P均<0.01],血清內脂素與BMI(r=-0.331)、HOMA-IR (r=-0.634)、WHR(r=-0.118)、FPG(r=-0.59)呈負相關,血清網膜素與BMI(r=-0.323)、HOMA-IR(r=-0.338)、WHR(r=-0.149)、FPG(r=-0.346)均呈負相關。結論閤併代謝綜閤徵的老年2型糖尿病患者血清內脂素、網膜素水平降低,併與BMI、HOMR-IR、腰臀比、空腹血糖呈負相關。
목적:관찰합병대사종합정적노년2형당뇨병환자혈청내지소(Visfatin)、망막소(Omentin)수평변화급기영향인소。방법선용병례-대조연구,공입선120례,병례조근거대사종합정급2형당뇨병진단표준입선합병대사종합정적노년2형당뇨병환자60례,동기입선년령、성별필배적60례건강체검자위대조조,매련면역흡부법검측내지소、망막소,상규측량신고、체중、혈압,계산BMI、HOMR-IR,검측공복혈당、공복이도소、총담고순、감유삼지등지표,비교량조내지소、망막소수평,병장내지소、망막소여기타지표진행상관분석。결과합병대사종합정적노년2형당뇨병환자혈청내지소、망막소수평강저[내지소:(1.08±0.69)μg/L vs.(4.06±1.04)μg/L,망막소(9.29±6.53)μg/L vs.(14.87±7.57)μg/L,P균<0.01],혈청내지소여BMI(r=-0.331)、HOMA-IR (r=-0.634)、WHR(r=-0.118)、FPG(r=-0.59)정부상관,혈청망막소여BMI(r=-0.323)、HOMA-IR(r=-0.338)、WHR(r=-0.149)、FPG(r=-0.346)균정부상관。결론합병대사종합정적노년2형당뇨병환자혈청내지소、망막소수평강저,병여BMI、HOMR-IR、요둔비、공복혈당정부상관。
Objective To investigate the change of plasma visfatin and omentin level in the population of the old type 2 diabetes with metabolic syndrome. Methods As a case control study, 120 cases were enrolled in the study, included normal control group (60 cases) and the old type 2 diabetes with metabolic syndrome group (60 cases). Plasma visfatin and omentin levels were assayed by ELISA, the relationship of plasma visfatin, omentin level with BMI, HOMA-IR, fasting plasma glucose levels were analysed. Results The visfatin and omentin level in the T2DM group, visfatin (1.08±0.69)μg/L vs. (4.06±1.04)μg/L, omentin (9.29±6.53)μg/L vs. (14.87±7.57)μg/L, P<0.01, the visfatin level were negatively related with BMI (r=-0.331), HOMA-IR (r=-0.634), WHR (r=-0.118), FPG (r=-0.59). The omentin level were negatively related with BMI (r=-0.323), HOMA-IR (r=-0.338), WHR (r=-0.149), FPG (r=-0.346). Conclusion The level of visfatin and omentin level in the T2DM group are decreased and negatively relate with BMI, HOMA-IR, WHR and FPG.